Introduction v-rel is an acutely transforming oncogene that belongs to the Rel/NF-kB family of transcription factors (Hrdlickova´et al., 1999) . Rel/NF-kB proteins are involved in multiple cellular processes including immune and inflammatory responses, cell growth control, embryonic development, stress responses and apoptosis (Pahl, 1999; Perkins, 2000) . In most cell types, Rel/NFkB dimers are sequestered in the cytoplasm by association with IkB inhibitory molecules. Appropriate extracellular signaling leads to the proteolysis of IkB resulting in the translocation of Rel/NF-kB complexes to the nucleus where they bind to decameric kB sites in the promoters of target genes to regulate their expression. The v-rel oncogene was derived by a nonhomologous recombination event between the turkey c-rel proto-oncogene and an avian retrovirus. Multiple mutations in v-Rel contribute to its oncogenicity by altering its DNA binding specificity and transactivation potential relative to c-Rel (Bose, 1992; Gilmore, 1999) . These mutations also render v-Rel less sensitive to IkBa inhibition allowing for its constitutive nuclear access in the absence of an appropriate exogenous signal (Hrdlickova´et al., 1995; Schatzle et al., 1995; Nehyba et al., 1997; Sachdev and Hannink, 1998) .
v-Rel transforms cells of hematopoietic origin and embryonic fibroblasts in vitro (reviewed by Bose (1992) ; Gilmore, (1999) ). The ability of v-Rel to transform these cells is characterized by their abilities to form colonies in soft agar and induce tumors in vivo. In addition, fibroblasts transformed by v-Rel undergo distinct morphological changes and have a prolonged lifespan. Transformation by v-Rel is mediated by the inappropriate activation or suppression of genes, which are normally regulated by Rel/NF-kB proteins. Efforts to identify genes induced by v-Rel have led to the identification of more than two dozen genes (You and Bose, 1998; Gilmore, 1999; Hrdlickova´et al., 1999 Hrdlickova´et al., , 2001 Nehyba et al., 2002) . However, only a few of these genes have been shown to contribute to the transformed phenotype. These include a cell surface adhesion molecule (DM-GRASP), the chemokine Mip-1b, an inhibitor of apoptosis (chIAP-1), transcription factors belonging to the AP-1 (c-Fos and c-Jun) and interferon response factor (IRF-4) families, and the reverse transcriptase of telomerase (TERT) (Zhang et al., 1995; Petrenko et al., 1997; You et al., 1997; Kralova et al., 1998; Hrdlickova´et al., 2001 Hrdlickova´et al., , 2006 .
Here, we report that TC10, a Rho family member, is upregulated in, and contributes to the transformation of fibroblasts by v-Rel. The Rho family consists of 22 proteins that are involved in signal transduction pathways which control a variety of biological functions including actin cytoskeleton remodeling, vesicle trafficking, cell polarity, cell adhesion, cell migration, proliferation, differentiation, apoptosis and transformation (reviewed by Symons (1996) ; Ridley (1997) ; Tapon and Hall (1997) ; Hall (1998) ; Mackay and Hall (1998) ; Zohn et al. (1998) ; Nobes and Hall (1999) ; Ellis and Mellor (2000) ; Evers et al. (2000) ; Aznar and Lacal (2001) ; Ridley (2001a, b) ; Frame and Brunton (2002) ). Rho GTPases are active when bound to GTP and inactive when bound to GDP. The exchange of GDP to GTP is catalysed by guanine nucleotide exchange factors (GEFs) and the hydrolysis of GTP is catlysed by GTPase-activating proteins (GAPs) (reviewed by Bernards and Settleman (2005) ; Rossman et al. (2005) ). The GTPase activity of Rho proteins is further regulated by guanine nucleotide dissociation inhibitors (GDIs) (reviewed by Dransart et al. (2005) ). These proteins inhibit the activation of RhoGTPases by preventing both the release of GDP as well as their localization to the plasma membrane where they are activated by GEFs.
TC10 has been cloned from vertebrates (human, mouse and rat), but is not present in budding yeast, suggesting that TC10 only functions in differentiated cells (Drivas et al., 1990; Neudauer et al., 1998; Tanabe et al., 2000; Chiang et al., 2002) . TC10 is predominantly localized on the plasma and endosomal membranes ) and has been implicated in various biological functions. TC10 has been reported to function in actin cytoskeleton organization (Neudauer et al., 1998; Murphy et al., 1999) , nerve regeneration (Tanabe et al., 2000) , and the activation of various kinases and transcription factors (Murphy et al., 1999; Murphy et al., 2001) . In addition, the involvement of TC10 in the translocation of glucose transporter 4 (GLUT4) upon insulin stimulation in muscle cells and adipocytes has been extensively characterized Jiang et al., 2001; Kanzaki and Pessin, 2001; Watson et al., 2001) . Furthermore, TC10 cooperates with activated Raf to transform fibroblasts and was shown to be important in Ras-mediated transformation of NIH3T3 cells (Murphy et al., 1999) . However, little is known about the transforming potential of TC10.
In this report, we describe the identification and cloning of the chicken ortholog of TC10. The expression and the activity of TC10 are upregulated in fibroblasts expressing v-Rel. Both wild-type TC10 and a gain-offunction mutant cooperate synergistically with v-Rel to transform fibroblasts. Moreover, a dominant-negative mutant of TC10 dramatically inhibits the ability of vRel to transform fibroblasts in culture. In addition to its role in v-Rel-mediated transformation, we demonstrate that the overexpression of either TC10 or a gain-offunction mutant of TC10 is sufficient to promote the transformation of primary fibroblasts in vitro.
Results

Isolation and cloning of chicken TC10 (TC10)
Differential display was employed to identify genes with altered expression in cells transformed by the v-rel oncogene. Differentially expressed cDNA fragments were identified by comparing the mRNA expression profiles from v-Rel-expressing cells with those of control cells. A 467 bp cDNA fragment was identified with significantly elevated expression in v-Rel-transformed CEFs relative to control cells. Sequencing of this gene fragment revealed that it contained 408 bp of 3 0 UTR and 59 bp of coding sequence that is highly homologous with the Rho small GTPase, TC10. Previous studies had indicated that certain Rho small GTPases are important in the regulation of cell proliferation and transformation (Zohn et al., 1998) . Therefore, we isolated the full-length open reading frame (ORF) of chicken TC10 (TC10) for further studies. The 5 0 end of the TC10 ORF was isolated by 5 0 RACE from an adapter-ligated cDNA library generated from v-Rel-expressing CEF cultures. The complete TC10 ORF is 642 nucleotides in length ( Figure 1a ). There are two potential translation start codons. The predicted protein translated from the first start codon has 214 amino acids with a molecular weight of 23.5 kDa. The second start codon is located 9 amino acids downstream of the first start codon and has a perfect Kozak sequence for translation initiation (Kozak, 1987) . The predicted protein translated from this codon is 205 amino acids in length with an estimated molecular weight of 22.8 kDa. Finally, the 408 bp 3 0 UTR contains several potential polyadenylation signals upstream of the poly (A) tract.
The predicted protein sequence of TC10 (from the first start codon) shares 93% identity with human TC10 (Figure 1b ). TC10 contains four highly conserved GTP binding domains, a Rho insert domain, effector domain and the C-terminal CAAX box. It also contains a plasma membrane targeting motif (CXXC) and a polybasic region in the hypervariable C-terminus, which are believed to be important for membrane targeting and regulation . The closest related Rho factor to TC10 is TCL, which shares 79% identity. Compared with other chicken Rho GTPases, TC10 shares 67% identity with Cdc42, 65% with Rac1, 63% with Rac2 and Rac3, 53% with RhoA, RhoB and RhoC and 45% with RhoF.
RNA levels of TC10 are elevated in Rel transformed cells To characterize the altered expression of TC10 in v-Rel transformed cells, Northern blot analysis was performed using RNA isolated from CEFs transformed by a retrovirus expressing v-Rel (DSv-Rel) or cells infected with a control virus (DS3). A TC10-specific probe detected four RNA species (4.2 kb, 1.9 kb and two high molecular weight species) that were expressed at 3 to 6-fold higher levels in cells transformed by v-Rel relative to control cells (Figure 2a ). These four species of TC10 likely represent alternatively spliced forms of TC10 since they were detected with probes encompassing either the TC10 contributes to v-Rel-mediated transformation S Tong et al 3'UTR or the entire ORF. The kinetics of TC10 expression during v-Rel transformation was also examined. CEFs were infected with DS3 or DSv-Rel and total RNA was isolated at different times after infection. Two days after infection, the expression of TC10 was increased two-fold in cells expressing v-Rel relative to control cultures (Figure 2b ). This is much earlier than cells become morphologically transformed by v-Rel (8-10 days after infection). The mRNA levels continued to increase until the 10th day after infection and maintained the same level at least 45 days after infection (data not shown). As v-Rel also transforms lymphoid cells, we examined the expression of TC10 in several hematopoietic cell lines by Northern blot analysis (Figure 2c ). TC10 was most highly expressed in AEV-1, a transformed erythroid cell line. TC10 was also expressed in three histologically distinct v-Rel transformed cell lines, B-cell lines DT95 and DT40 and a macrophage cell line BM2. By contrast, TC10 was poorly expressed in the Marek's disease virus transformed T-cell lines, MSB-1 and RP-1.
The elevated expression of other Rho family members has been correlated with oncogenesis in a variety of systems. To determine whether the upregulation of TC10 mRNA in v-Rel transformed cells is unique, the expression of avian Rho GTPases was evaluated in fibroblasts transformed by the expression of v-Rel or the overexpression of c-Rel (Figure 3 ). The expression of TC10 was induced almost three-fold in cells transformed by v-Rel and c-Rel relative to control cells. The expression of RhoC was elevated three-fold in v-Reltransformed cells but was not significantly altered in The expression and activity of TC10 protein is upregulated in Rel-transformed CEFs To determine whether the increase in TC10 RNA levels in v-Rel-transformed cells results in a corresponding increase at the protein level, a rabbit polyclonal antiserum was generated against a synthetic peptide (KGPKTLARLNDMKEKPLS) which contains the Rho insert domain (underlined, amino acids 138-153) of TC10. To verify the specificity of the antisera, immunoprecipitation experiments were performed with in vitro translated chicken TC10 and the closely related RhoGTPase, TCL. The in vitro translated proteins were heat denatured in the presence of sodium dodecyl sulfate (SDS) to expose all available epitopes, and immunoprecipitated with antisera against the TC10-specific peptide (Figure 4a ). Only the in vitro translated TC10 was detected in the immunopreciptiates from these experiments. This antisera was employed to determine the steady-state level of TC10 protein in c-Rel and v-Rel transformed cells by Western blot analyses (Figure 4b , top panel). A 20-25 kDa protein was detected in wholecell lysates from CEF cultures, which corresponds to the predicted size of TC10. The endogenous level of TC10 was very low in control CEFs, and increased approximately 3 to 6-fold in both c-Rel and v-Rel transformed CEFs. The increase in the level of TC10 corresponded with the increase in the steady-state level of TC10 mRNA in these transformed cells (Figure 4c ). The GTP-bound form of TC10 is biologically active and able to bind downstream effectors to exert its function. To determine if the activity of TC10 was increased in response to the increase in expression of TC10 in Rel-transformed cells, a GST-CRIB (Cdc42 and Rac interactive binding) domain pull-down assay was performed. The CRIB domain is a conserved sequence identified in a variety of downstream effectors of Cdc42 and Rac and the CRIB domain of PAK1 was demonstrated to specifically bind to the GTP-bound forms of human TC10, Cdc42 and Rac (Benard et al., 1999; Murphy et al., 1999) . GST-CRIB domain agarose beads were incubated with cell extracts prepared from control CEF cultures or those transformed by c-Rel or v-Rel and the amount of GTP-bound TC10 pulleddown by the beads was detected by immunoblotting using TC10-specific antiserum. Significantly more GTPbound TC10 was detected in both c-Rel and v-Rel transformed cells relative to control cells, indicating that the activity of TC10 is increased in Rel-transformed CEF cultures (Figure 4 , middle panel). Two forms of TC10 were observed in these assays and the lower molecular weight form was the same size as the TC10 protein detected in whole-cell extracts. Treatment of lysates with protein phophatase did not prevent the appearance of the higher molecular weight form (data not shown). TC10 is one of a few RhoGTPases that can be modified by isoprenylation (either geranylgeranylation or farnesylation) at its C-terminal CAAX motif as well as palitoylation of the polybasic sequence upstream of this motif . Therefore, it is likely that the two forms of TC10 represent different C-terminal post-traslational modifications.
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Expression of TC10, TC10Q76L, TC10T32N and coexpression with v-Rel in CEFs
The increased levels of mRNA, protein, and activity of TC10 in Rel-transformed CEF cultures suggests that TC10 contributes to v-Rel-mediated transformation S Tong et al TC10 may be important in Rel-mediated transformation. To evaluate the role of TC10 in transformation, mutants of TC10 with altered biochemical activities were constructed. Gain-of-function (TC10Q75L) and dominant-negative (TC10T31N) mutants of human TC10 have been previously described (Murphy et al., 1999; Neudauer et al., 1998) . TC10Q75L is unable to hydrolyze bound GTP, resulting in a constitutively active protein. TC10T31N does not bind GTP and only inefficiently binds GDP. The expression of this dominant-negative mutant is believed to block endogenous TC10 function by sequestering GEFs. The corresponding mutations in chicken TC10 (TC10Q76L and TC10T32N) were made by site-directed mutagenesis. These two mutants and wild-type TC10 were cloned into an SNV-based retroviral vector, which allowed the expression of a gene encoding neomycin resistance and each of the TC10 proteins. To verify the biochemical activities of these TC10 proteins, CEF cultures were coinfected with the viruses expressing TC10, TC10Q76L or TC10T32N, and a control virus (DS3) or a virus expressing v-Rel (DSv-Rel). Cells were grown under G418 selection to maintain expression of the viruses encoding TC10 proteins. Cell lysates were prepared 20 days after infection, and the expression of TC10 and vRel was determined by Western blot analysis (Figure 5a) . Each of the forms of TC10 was expressed at levels higher than the endogenous protein (top panel). The expression of TC10 proteins did not alter the levels of v-Rel (bottom panel). The relative amount of GTPbound TC10 in each of these cells was determined by GST-CRIB domain pull-down assays (middle panel). As expected, cells expressing the gain-of-function TC10 had high levels of the GTP-bound protein, while cells expressing the dominant-negative mutant did not contain detectable levels of the GTP-bound form. Cells overexpressing wild-type TC10 had intermediate levels of GTP-bound protein. Overexpression of the gain-of-function mutant or wild-type TC10 in cells expressing v-Rel resulted in higher levels of GTP-bound TC10 than observed in cells expressing v-Rel alone. Coexpression of the dominant-negative mutant prevented the induction of endogenous, activated TC10 by v-Rel. Due to the high levels of activated TC10 present in cells overexpressing the gain-of-function TC10, only one fourth the amount of cell extract used in Figure 4 was used in these assays and therefore, the elevated levels of activated TC10 in extracts from v-Rel transformed cells are not evident.
TC10 induces in vitro transformation characteristics in primary fibroblasts and contributes to v-Rel-mediated transformation To evaluate whether TC10 contributes to transformation of fibroblasts by v-Rel, TC10 activity was either increased or decreased by the overexpression of wildtype TC10, the gain-of-function mutant, or the dominant-negative mutant in v-Rel expressing fibroblasts. CEF cultures were coinfected with both SNV-based viruses expressing the various TC10 genes and DS3 retroviruses expressing v-Rel as described above. Stable cell cultures were selected with G418 for 15 days and their ability to form colonies in soft agar was evaluated (Figure 5b ). Both TC10 and the gain-of-function mutant synergistically cooperated with v-Rel to increase colony formation in soft agar (four-and seven-fold, respectively). Moreover, coexpression of the dominant-negative mutant of TC10 with v-Rel dramatically decreased (78%) the number of colonies relative to cells expressing v-Rel alone. These results indicate that TC10 contributes to v-Rel-mediated transformation of fibroblasts.
Previous studies have shown that the activated form of human TC10, while not transforming alone, can cooperate with activated Raf to transform NIH3T3 cells (Murphy et al., 1999) . In contrast, our studies Total RNA was isolated after cultures infected with viruses expressing cRel and v-Rel became transformed. RNA (10 mg) was analysed for the expression of TC10, TCL, cdc42, rhoA, rhoB, rhoC, rhoG, rac1, rac2 and rac3 by Northern blot (top panels). Hybridization of an oligonucleotide to the 18S ribosomal RNA is shown in the lower panels as a control for loading. The probe used in each hybridization is indicated to the right of each panel. Only the 4.2 kb mRNA hybridizing to the TC10 probe is shown. The relative abundance of each mRNA was determined by phosphorimager analysis after standardizing for RNA loading with 18S rRNA and is indicated below the 18S rRNA panels.
TC10 contributes to v-Rel-mediated transformation
S Tong et al demonstrated that the overexpression of wild-type TC10 alone weakly promoted colony formation in soft agar (Figure 5b ). In addition, the gain-of-function mutant induced colony formation four-fold more efficiently than wild-type TC10. To further characterize the effects of the overexpression of TC10 on primary fibroblast cultures, saturation density experiments were performed ( Figure 5c ). The overexpression of TC10 increased the saturation density of CEFs by more than 40%, while the expression of the gain of function mutant of TC10 enhanced the saturation density of these cells by twofold. The combined results of the soft agar colony formation and saturation density experiments demonstrate that overexpression of TC10 is sufficient for the in vitro transformation of primary fibroblasts.
Discussion
In this report, we describe the isolation and characterization of the chicken homolog of TC10. The expression and activity of TC10 is upregulated by the v-Rel oncoprotein and the overexpression of the protooncoprotein c-Rel. We further demonstrated that the elevated activity of TC10 is important for v-Relmediated transformation of CEFs and that the overexpression of TC10 alone induces the in vitro transformation of primary fibroblasts.
Increases in TC10 expression and activity contribute to v-Rel-mediated transformation v-Rel transforms cells by inappropriately altering the expression of genes regulated by the Rel/NF-kB family of transcription factors. More than two dozen genes have been identified that exhibit altered expression in response to v-Rel (Gilmore, 1999; Hrdlickova´et al., 1999) . However, only a few of these genes have been shown to contribute to the phenotype of v-Reltransformed cells. In this report, we demonstrate that TC10 is unique among the Rho family of small GTPases in that it exhibits elevated expression in cells transformed by both the expression of v-Rel and by the overexpression of c-Rel (Figure 3) . Further, the elevated levels of TC10 mRNA correspond with an increase in TC10 protein and activity in Rel-transformed cells relative to control cells (Figure 4 ). The coexpression of TC10 or a gain-of-function mutant of TC10 (TC10Q75L) synergistically cooperated with v-Rel to enhance the colony forming ability of CEFs ( Figure 5 ). By contrast, the expression of a dominant-negative mutant of TC10 (TC10T32N) greatly decreased the ability of v-Rel-expressing fibroblasts to form colonies in soft agar. These results demonstrate that TC10 plays an important role in v-Rel-mediated transformation. The mechanisms by which TC10 contribute to cell transformation, have yet to be defined. Potential downstream effectors of TC10 include p21-activated kinase (PAK), mixed lineage kinase 2, myotonic dystrophyrelated Cdc42 kinase, Borgs, N-WASP (Wisktt-Aldrich syndrome protein), and the mammalian partitiondefective homolog Par6 and CAL (cystic fibrosis transmembrane conductance regulator-associated ligand) (Neudauer et al., 1998; Joberty et al., 1999; Cheng et al., 2005) . In addition, TC10 mediates multiple signaling pathways leading to the activation of kinases The levels of TC10 in whole-cell lysates (75 mg) from CEFs transformed by v-Rel, c-Rel or infected with DS3 empty vector were determined by Western blot analysis using the TC10-specific antiserum ID1 (top panel). The levels of GTP-bound TC10 in these cells were determined by a GST-CRIB pull-down assay followed by Western blot analysis (middle panel). The expression of v-Rel and c-Rel in these cell lysates were detected with the monoclonal antibody HY87 (bottom panel). (c) Total RNA was isolated from the cultures described above. RNA (10 mg) was analysed for the expression of TC10 by Northern blot (top panel). Methylene blue staining of the 18S ribosomal RNA is shown in the lower panel as a control for loading.
TC10 contributes to v-Rel-mediated transformation S Tong et al such as c-Jun N-terminal kinase (JNK) and PAK, and the transcription of reporter constructs containing the cyclin D1 promoter or binding sites for serum response factor (SRF) or NF-kB (Murphy et al., 1999; Murphy et al., 2001) . Although a number of these pathways and proteins have been implicated in transformation, none have been shown to be required for the ability of TC10 to participate in the transformation of cells.
Some known functions of TC10 are enticing possibilities for its role in v-Rel-mediated transformation. Activated TC10 has been shown to induce JNK activity and we have previously demonstrated that AP-1 activity is important for anchorage-independent growth of v-Rel-transformed fibroblasts (Kralova et al., 1998) . A dominant-negative mutant of c-Jun greatly decreased colony formation of v-Rel-transformed CEFs in soft agar. The demonstrated importance of c-Jun activity suggests that increased activity of JNK, the major kinase for activating c-Jun, may contribute to v-Relmediated transformation. However, the expression of TC10Q76L and TC10T32N in v-Rel-transformed CEFs does not alter the activity of JNK in a manner that is consistent with it being activated by TC10 during transformation (data not shown).
TC10 has been shown to facilitate the translocation of the glucose transporter GLUT4 from the endosome to the plasma membrane in muscle cells and adipocytes stimulated with insulin (Kanzaki and Pessin, 2001; Watson et al., 2001; Chang et al., 2002) . Interestingly, increased glucose uptake is a common characteristic of tumor cells and v-Rel transformed CEFs take up glucose more rapidly than normal fibroblasts (Warburg, 1930; Franklin et al., 1977) . Therefore, TC10 may contribute to cell transformation by increasing glucose transport. However, the expression of the dominantnegative mutant of TC10 did not alter the ability of vRel transformed cells to uptake 3 H-glucose from the culture media (data not shown). Future studies will focus on defining the pathways through which TC10 participates in the transformation of CEFs by v-Rel. 
TC10 transforms primary fibroblasts in culture
Human TC10 has been implicated in the Ras-mediated transformation of fibroblast cell lines (Murphy et al., 1999) . The overexpression of the gain-of-function mutant, TC10Q75L, cooperated with the active form of Raf-CAAX to induce foci formation of NIH3T3 cells, but overexpression of TC10Q75L alone did not. The dominant-negative mutant, TC10T31N, suppressed the focus formation ability of these cells. These observations are similar to those obtained for Cdc42, Rac1, RhoA and RhoB (Prendergast et al., 1995; Qiu et al., 1995 Qiu et al., , 1997 Osada et al., 1997; Westwick et al., 1997; Whitehead et al., 1998) . Moreover, previous studies indicated that the constitutively active mutants of Cdc42 (G12V) and Rac (G12V) increased the colony formation ability of mammalian fibroblast cell lines in soft agar. Although there are a large number of reports describing the oncogenic potential of various RhoGTPases, all of these studies were performed with immortalized cell lines, such as NIH3T3 cells (Perona et al., 1993; van Leeuwen et al., 1995; del Peso et al., 1997; van Golen et al., 2000; Singh et al., 2004) . In contrast to these studies, the experiments described here employed primary fibroblast cultures and indicate that TC10 alone is sufficient to transform primary fibroblasts in culture. The overexpression of TC10 or TC10Q76L from retroviral vectors allowed for the anchorageindependent growth of CEFs (Figure 5b) . Furthermore, the overexpression of TC10Q76L enhanced the saturation density of CEFs (Figure 5c ). This is the first report of the overexpression of a Rho small GTPase alone inducing the in vitro transformation of primary fibroblast cultures. Previous studies demonstrated that aberrant expression and activation of Rho small GTPases are important in tumor generation and progression, although mutation of Rho GTPase genes rarely occurs in tumors (Keely, 2001; Boettner and Van Aelst, 2002) . Elevated expression of RhoA, RhoC, Rac1B and Rac2 were found in a variety of cancers including head and neck squamouscell cancers, ductal adenocarcinomas of the pancreas, inflammatory breast cancer cells, colon cancers and lung cancers (Suwa et al., 1998; van Golen et al., 2000; Abraham et al., 2001) . Aberrant expression of Rho and Rac have been found in even moderately differentiated tumors, suggesting that Rho proteins may be early markers of tumor progression (Moscow et al., 1994; Suwa et al., 1998) . This report provides the first evidence that the overexpression of TC10 results in transformation of primary cells in culture. The ability of proteins to transform CEFs has been a powerful prognosticator of their involvement in the development of human cancer. Although CEFs bear little resemblance to the cell types of most human tumors, the orthologs of a large number of wild-type and mutant proteins (such as c-Rel, c-Src, c-Myc and IRF-4) that transform CEFs are involved in the development of a variety of histologically distinct neoplasias, including lymphomas, myelomas, colon and breast cancers (Kato et al., 1986; Frykberg et al., 1987; Kralova et al., 1994; Iida et al., 1997; Nass and Dickson, 1997; Irby et al., 1999; Rayet and Gelinas, 1999; Hrdlickova´et al., 2001) . Therefore, the ability of TC10 to induce the in vitro transformation of CEFs suggests that TC10 may also serve as a marker for tumor progression.
Materials and methods
Cloning and mutagenesis of TC10 Differential display was performed using total RNA from vRel transformed and control cells as described previously (You et al., 1997; You and Bose, 1998) . A repertoire of cDNA fragments was amplified from each cell type using an RNAimage kit (GenHunter Corp., Nashville, TN, USA) with the H-T 11 G primer and a random primer set (H-AP1 to H-AP8). The full-length ORF of TC10 was obtained by 5 0 RACE. Two adaptor-ligated cDNA libraries were generated with RNA isolated from v-Rel transformed CEFs using the Marathon cDNA amplification kit (Clontech, Palo Alto, CA, USA) and the SMART cDNA synthesis kit (Clontech) according to the manufacturer's protocol. A partial sequence of TC10 was amplified from the Marathon cDNA library by polymerase chain reaction (PCR) using the 5 0 PCR primer (5 0 -AAGCAGTGGTATCAACGCAGAGT-3 0 , Clontech) and the TC10-specific primer CB22 (5 0 -TCACAGTAAGCCTGGC CATTGTCA-3 0 ). The remaining sequences encoding the Nterminal domain were isolated from the SMART cDNA library using the UPMS primer (Clontech) and the TC10-specific primer CB23 (5 0 -CACTCCACATAGCAGTAGGC TCCT-3 0 ) by touchdown PCR. PCR was performed as follows: 941C for 1 min, five cycles of 941C for 30 s and 721C for 4 min, five cycles of 941C for 30 s and 701C for 4 min, followed by 20-25 cycles of 941C for 20 s and 681C for 4 min. PCR products were sequenced by an automated Perkin-Elmer ABI PRISM 377 sequencer at the DNA Core Facility at the University of Texas at Austin. The sequence of TC10 reported in this paper was submitted to GenBank with accession number AF372468.
TC10 was cloned into the NotI and SacII sites in pBluescript II SK (À). Point mutations in TC10 were made with a Transformer site-directed mutagenesis kit (Clontech) according to the manufacturer's protocol. To make the Q76L and T31N mutants, mutagenic primers M1 (5 0 -CACCGCCGG GCTGGAAGACTAT-3 0 ) and M2 (5 0 -GTGGGCAAGAAC TGCCTGCTGA-3 0 ) as well as a selection primer SP2 (5 0 -GGCCCCCCCTTAAGGTCGACGG-3 0 ) were used. The underlined nucleotides define the point mutations.
Cell lines and tissue culture CEF cultures were prepared from 10 to 11-day-old SPAFAS (Charles River SPAFAS, North Franklin, CT, USA) or SPF-SC (Hy-Vac, Adel, IA) embryos and grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% newborn calf serum (Atlanta Biologicals, Norcross, GA, USA), 5% chicken serum (Invitrogen, Carlsbad CA, USA), 100 U/ml penicillin and 50 mg/ml streptomycin in 8% CO 2 at 371C. The DT40, DT95, BM2, 123/12, 160/2, 123/6 T, MSB-1, RP-1 and AEV-1 cell lines were maintained in the same conditions as CEFs. AEV-1 is an avian erythroblastosis virustransformed erythroid cell line (Rao et al., 1990) . DT95 and DT40 are c-myc-transformed chicken B-cell lines (Baba et al., 1985) . MSB-1 and RP-1 are T-cell lines derived from lymphomas induced by Marek's disease virus (Akiyama and Kato, 1974; Nazerian et al., 1977) . BM2 is a macrophage-like cell line derived from avian myeloblastosis virus (AMV) transformed yolk sac cells (Moscovici et al., 1982) . 123/12 (B-cell), 160/2 (T-cell) and 123/6T (non-B/non-T) are TC10 contributes to v-Rel-mediated transformation S Tong et al v-Rel-transformed cell lines (Hrdlickova´et al., 1994b) . C4-1 is a B-cell line transformed by S2A3v-Rel and was cultured in DMEM supplemented with 6% newborn calf serum, 2% chicken serum (Zhang and Bose, 1989; Romero and Humphries, 1995) . D17 is a dog osteosarcoma cell line and was maintained in DMEM containing 8% newborn calf serum (Dougherty and Temin, 1988) .
Retroviral vectors
DS3, DSc-Rel and DSv-Rel are replication competent Rous sarcoma-based retroviruses that were generated using the pDS3, pDSc-Rel, pDSv-Rel and pREP vectors as described previously (Okuno et al., 1991; Kralova et al., 1998) . The spleen necrosis virus (SNV)-based bicistronic retroviral vector pMJ612 was derived from pJD216neoHy (Dougherty and Temin, 1986 ) and contains two long terminal repeats (LTR), neomycin and hygromycin resistance genes, and a gene encoding the green fluorescence protein (GFP). The sequences between the SmaI site and the SalI site of pMJ612 encode the hygromycin resistance gene and were replaced with double-stranded adapters (5 0 -GCCACCATGCCCGGGG GAGGGCGGGCT-3 0 and 5 0 -CATTGTCGACTCACGTGA TCAAACAGCAGT-3 0 ) to facilitate the cloning of the ORFs of TC10, the gain-of-function mutant TC10Q76L, or the dominant-negative mutant TC10T32N. A Kozak sequence (GCCACC) was added to the 5 0 end of the start codon of TC10 to enhance translation initiation. The pSW253 plasmid contains a genomic clone of a replication competent helper virus, REV-A, which was employed for packaging the SNVbased viruses (Watanabe and Temin, 1983) .
The SuperFect transfection reagent (Qiagen, Valencia, CA, USA) was used for the introduction of the retroviral constructs into CEF cultures. CEF cultures (7 Â 10 5 ) were seeded into 60 mm plates and were transfected when cells were 50-70% confluent (approximately 18-24 h later). DS3, DSc-Rel and DSv-Rel viral supernatant fluids were prepared and titered by an immunochemical titration assay as described previously (Kralova et al., 1998) . To prepare recombinant SNV-based viruses, the constructs were introduced into CEF cultures as described above using 5 mg of the pMJ612 construct, 200 ng of the pSW253 construct and 20 ml of SuperFect reagent for each 60 mm culture plate. Twenty-four hours after transfection, cells were placed under selection in media containing 500 mg/ml of G418. Viral supernatant fluids were harvested 7-12 days after drug selection. The infectious units (IU) of the MJ612 virus were determined by infection of D17 cells and quantitation of neomycin-resistant colonies as described previously (Dougherty and Temin, 1986) .
To infect CEF cultures with retroviruses, 1.8 Â 10 6 cells were seeded into 100 mm tissue culture plates and grown for 18 h or until they reached 50-70% confluence. Cells were coinfected at a multiplicity of infection of 1.5 with viral supernatant fluids containing DS3-and SNV-based viruses. Forty-eight hours after infection, cultures were maintained in medium containing 500 mg/ml G418.
Northern blot analysis
Total RNA was isolated from CEF cultures or chicken transformed cell lines using RNAwiz (Ambion, Austin, TX, USA). RNA was separated in a 1% denaturing agarose gel propanesulfonic acid) and 2% formaldehyde) in 20 mM MOPS and transferred to a Hybond N þ nylon membranes (Amersham Pharmacia Biotechnology, Piscataway, NJ, USA). The relative amount of RNA on the membrane was determined by quantitating the intensity of ethidium bromide staining, methylene blue staining, or hybridization with a probe specific for the 18S rRNA. Membranes were hybridized with [ 32 P]dCTP-labeled DNA probes using UltraHyb solution (Ambion) at 42 or 551C. Probes were prepared by random priming (Prime-A-Gene kit, Promega, Madison, WI, USA) and purified using Micro Biospin 30 columns (Bio-Rad Laboratories, Hercules, CA). The probes for detecting TC10 were the 467 bp cDNA identified by differential display or the whole TC10 ORF. Probes for chicken Rho family member were derived from the cDNAs of CDC42 (GI:45384261), RhoA (GI:45382666), RhoC (GI:71143153) and Rac1(GI:3184509) and the ESTs of TCL (ChEST66d11), RhoB (chEST66P8), RhoG (ChEST455i12), Rac2 (ChEST231i16) and Rac3 (chEST989E16).
Western blot analysis and antisera For Western blot analysis, cell lysates were separated by 12% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and subsequently transferred to an Optitran nitrocellulose membrane (Schleicher and Schuell, Keene NH). A rabbit anti-TC10 serum, TC10 (ID1) was generated against an 18 amino acid peptide (KGPKTLARLNDMKEKPLS) containing the specific Rho insert domain of TC10. The peptide was synthesized in the Protein Facility of the University of Texas at Austin. Monoclonal antibody HY87 was used for detecting both v-Rel and c-Rel (Hrdlickova´et al., 1994a) . Secondary antibodies used for this study were horseradish peroxidase-conjugated goat anti-rabbit IgG and goat anti-mouse IgG antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). The signal was detected with the Western lightning chemiluminescence reagent plus (Perkin-Elmer Life and Analytical Sciences, Wellesley, MA, USA).
In vitro translations and immunopreciptiations
In vitro translations were performed using the T7 polymerase based TNT Coupled Reticulocyte Lysate System (Promega, Madison, WI, USA) with [ 35 S]-methionine according to the manufacturer's directions. Genes encoding TC10 and TCL were expressed from the pBluescript or pGEM-T-EZ expression vectors, respectively. Approximately equal amounts of translated TC10 and TCL were diluted in 20 ml of low immunoprecipitation buffer (IPB) (25 mM Tris pH7.5, 150 mM NaCl, 2 mM ethylenediamine-N,N,N 0 ,N 0 -tetraacetic acid (EDTA), 0.5% NP-40) containing 10% SDS and denatured at 1001C for 5 min. The denatured proteins were diluted with low IPB to a final volume of 200 ml and used in immunopreciptiation experiments with 5 ml of either normal rabbit serum or serum specific to TC10. Reactions were rotated for 1 h at 41C. Protein A Sepharose beads were added to the precipitations and rotated at 41C for 1 h. Immune complexes bound to the Protien A Sepharose beads were washed three times with 1 ml of low IPB and removed from the beads by boiling the beads in 25 ml of loading buffer. Immunoprecipitates were resolved by 12% SDS-PAGE.
GST-CRIB domain pull-down assay A DH-10B strain of Escherichia coli transformed by a pGEX-4T construct containing a GST-CRIB domain fusion gene was a gift from Dr Suranganie Dharmawadahane (University of Texas at Austin). This CRIB domain corresponds to amino acids 74-89 of PAK1. The protocols for purification of the fusion protein and the pull-down assay were previously described (Benard and Bokoch, 2002) . The expressed fusion proteins were purified with glutathione-agarose beads (Sigma, St Louis, MO, USA), and the beads were incubated with lysates from CEF cultures. Proteins pulled down with the beads were separated on 12% SDS-PAGE, transferred to a nitrocellulose membrane, and detected with TC10 (ID1) antiserum.
In vitro transformation assays Soft agar colony formation assays were performed using CEF cultures that were coinfected with DS3 and pMJ612 viruses and selected in G418 for 15 days. CEFs (1 Â 10 5 ) were placed in 4 ml of plating media (DMEM containing 15% fetal bovine serum, 5% chicken serum, 100 U/ml penicillin, 50 mg/ml streptomycin, 500 mg/ml G418 and 0.37% Noble agar) and plated on a bed of medium containing 0.75% agar in 60 mm tissue culture plates. Cells were fed with 3 ml of plating medium every 10 days. The number of colonies was scored microscopically 4 weeks after seeding.
Saturation density experiments were performed using CEF cultures that were infected with SNV-based retroviruses and selected in G418 for 20 days. Multiple 60 mm culture plates were seeded with 1 Â 10 5 cells of each infection in 4 ml of media containing G418. The number of cells from three plates of each infection was determined with a hemocytometer 48 h after seeding. Culture media was changed everyday. The cell number from three plates from each infection was determined every day until the cells detached from the plate.
